Evidence map›Paper›PMID 34627310›Full record

ArticleRetrovirology2021

Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators.

Shiyu Zhang, Andrew P Holmes, Alexej Dick, Adel A Rashad, Lucía Enríquez Rodríguez, Gabriela A Canziani, Michael J Root, Irwin M Chaiken

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Shiyu Zhang *Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, PA, USA.ORCID 0000-0003-4586-0605
Andrew P Holmes *Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, PA, USA.
Alexej DickDepartment of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, PA, USA.
Adel A RashadDepartment of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, PA, USA.
Lucía Enríquez RodríguezFaculty of Experimental Science, Francisco de Vitoria University, Madrid, Spain.
Gabriela A CanzianiDepartment of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, PA, USA.
Michael J RootDepartment of Microbial Infection and Immunity, The Ohio State University College of Medicine, OH, Columbus, USA. root.186@osu.edu.
Irwin M ChaikenDepartment of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, PA, USA. imc23@drexel.edu.
Drexel University · USThe Ohio State University · USUniversidad Francisco de Vitoria · ES

Funding

Understanding Envelope Function in HIV-1 Infection: The Design, Synthesis and Validation of Small Molecule HIV-1 Env InhibitorsP01GM056550 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI ABRAMS, CAMERON F · 1997 to 2018
$31.2M
Understanding Envelope Function in HIV-1 Infection: The Design, Synthesis and Validation of Small Molecule HIV-1 Env InhibitorsP01AI150471 · NIAID · DREXEL UNIVERSITY · PI HENDRICKSON, WAYNE A. · 2019 to 2022
$7.8M
MECHANISMS OF HIV-1 MEMBRANE FUSIONR01GM066682 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI ROOT, MICHAEL JEFFREY · 2002 to 2019
$3.9M
Bifunctional Chimeras Targeting Both HIV-1 Env and Host Cell Co-receptorsR01AI128815 · NIAID · DREXEL UNIVERSITY · PI CHAIKEN, IRWIN M · 2017 to 2021
$1.0M
Biacore S200 Surface Plasmon Resonance Instrument for a Shared Resources FacilityS10OD027009 · OD · DREXEL UNIVERSITY · PI CHAIKEN, IRWIN M · 2019 to 2019
$365k
Mechanisms of HIV-1 Env-Mediated Membrane FusionR01AI150490 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI ROOT, MICHAEL JEFFREY · 2020 to 2020
$332k
NIAID NIH HHS P01 AI150471NIAID NIH HHS R01 AI128815NIAID NIH HHS R01 AI150490NIGMS NIH HHS P01GM56550NIGMS NIH HHS R01 GM066682NIH HHS S10 OD027009
6 · The paper itself

Abstract

backgroundWe previously developed drug-like peptide triazoles (PTs) that target HIV-1 Envelope (Env) gp120, potently inhibit viral entry, and irreversibly inactivate virions. Here, we investigated potential mechanisms of viral escape from this promising class of HIV-1 entry inhibitors.

resultsHIV-1 resistance to cyclic (AAR029b) and linear (KR13) PTs was obtained by dose escalation in viral passaging experiments. High-level resistance for both inhibitors developed slowly (relative to escape from gp41-targeted C-peptide inhibitor C37) by acquiring mutations in gp120 both within (Val255) and distant to (Ser143) the putative PT binding site. The similarity in the resistance profiles for AAR029b and KR13 suggests that the shared IXW pharmacophore provided the primary pressure for HIV-1 escape. In single-round infectivity studies employing recombinant virus, V255I/S143N double escape mutants reduced PT antiviral potency by 150- to 3900-fold. Curiously, the combined mutations had a much smaller impact on PT binding affinity for monomeric gp120 (four to ninefold). This binding disruption was entirely due to the V255I mutation, which generated few steric clashes with PT in molecular docking. However, this minor effect on PT affinity belied large, offsetting changes to association enthalpy and entropy. The escape mutations had negligible effect on CD4 binding and utilization during entry, but significantly altered both binding thermodynamics and inhibitory potency of the conformationally-specific, anti-CD4i antibody 17b. Moreover, the escape mutations substantially decreased gp120 shedding induced by either soluble CD4 or AAR029b.

conclusionsTogether, the data suggest that the escape mutations significantly modified the energetic landscape of Env's prefusogenic state, altering conformational dynamics to hinder PT-induced irreversible inactivation of Env. This work therein reveals a unique mode of virus escape for HIV-1, namely, resistance by altering the intrinsic conformational dynamics of the Env trimer.

Indexed as

Drug Resistance, ViralAnti-HIV AgentsBinding SitesHIV-1HIV Envelope Protein gp120HIV InfectionsHumansMolecular Docking SimulationMutationPeptidesProtein ConformationTriazolesVirus InternalizationAnti-HIV AgentsHIV Envelope Protein gp120PeptidesTriazolesConformational dynamicsEntry inhibitorEnvelope glycoproteinsgp120 sheddingHIV-1Isothermal titration calorimetry (ITC)Macrocyclic peptideResistance mechanismSurface plasmon resonance (SPR)Virus escape

Identifiers

PMID34627310
PMCPMC8501640
OpenAlexW3205066747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.